Last reviewed · How we verify

NCT07302737

Delirium and Heart Failure

Not yet recruiting Last updated 24 December 2025
What this trial tests

trial testing Comprehensive Geriatric Assessment in Heart Failure in 100 participants. Not yet recruiting.

Timeline
20 January 2026
Primary endpoint
1 July 2026
1 August 2026

Quick facts

Lead sponsorAin Shams University
StatusNot yet recruiting
Study typeOBSERVATIONAL
Enrollment100
Start date20 January 2026
Primary completion1 July 2026
Estimated completion1 August 2026
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

60 and older, any sex, with Heart Failure or Delirium Confusional State. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Biomarkers such as Systemic Immune-Inflammation Index (SII) and TG/Glucose Ratio (TyG) have shown promise in predicting delirium, reflecting the roles of inflammation and metabolic disturbances in its pathophysiology. This study aims to compare the predictive value of SII and the TyG ratio among other chemical and physiological biomarkers for diagnosing delirium and detecting its severity in older adults with heart failure. These biomarkers reflect different pathophysiological pathways implicated in delirium, including inflammation, cardiovascular stress, and metabolic dysfunction. By evaluating their individual and combined predictive abilities, this research seeks to identify potential tools for early identification of patients at high risk for delirium

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Comprehensive Geriatric Assessment

Trials testing the same drug.

Other recruiting trials for Heart Failure

Currently open trials in the same condition.

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07302737.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing